Smoking and inflammatory bowel disease: a meta-analysis

Area of Science:

• Gastroenterology
• Epidemiology
• Environmental Health

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn disease (CD) and ulcerative colitis (UC), are chronic conditions with complex etiologies.
• Environmental factors are increasingly recognized as significant contributors to IBD development and progression.

Purpose of the Study:

• To conduct a meta-analysis assessing the specific effects of smoking on the incidence and prevalence of Crohn disease (CD) and ulcerative colitis (UC).
• To differentiate the impact of smoking status (current, former) on the two primary forms of IBD.

Main Methods:

• A comprehensive meta-analysis was performed using data from MEDLINE and EMBASE databases (January 1980 to January 2006).
• Studies examining the relationship between smoking and IBD were identified using relevant keywords.
• Data were extracted based on predefined inclusion/exclusion criteria, and odds ratios (OR) were calculated using random-effects models.

Main Results:

• The analysis included 13 studies for UC and 9 for CD, totaling 245 articles initially screened.
• Current smoking was associated with an increased risk of Crohn disease (OR, 1.76; 95% CI, 1.40-2.22).
• Former smoking showed an association with ulcerative colitis (OR, 1.79; 95% CI, 1.37-2.34), while current smoking demonstrated a protective effect against UC development (OR, 0.58; 95% CI, 0.45-0.75).

Conclusions:

• This meta-analysis confirms smoking as a significant environmental factor influencing inflammatory bowel disease.
• The study highlights distinct and opposing effects of smoking on Crohn disease versus ulcerative colitis.
• Findings underscore the importance of considering smoking status in IBD research and clinical management.